Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

Swiss (SMI) Biotech Industry Analysis

UpdatedNov 21, 2024
DataAggregated Company Financials
Companies7
  • 7D-11.1%
  • 3M21.9%
  • 1Y103.0%
  • YTD105.5%

Over the last 7 days, the Biotech industry has dropped 14%, driven by declines from every company within the industry. In the past year, the industry has gained 93%. Looking forward, earnings are forecast to grow by 17% annually.

Industry Valuation and Performance

Has the Swiss Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 21 Nov 2024CHF 1.8bCHF 331.2m-CHF 86,988,629.001.6x-20.2x5.3x
Sat, 19 Oct 2024CHF 1.8bCHF 333.1m-CHF 82,023,629.001.8x-21.6x5.3x
Mon, 16 Sep 2024CHF 1.6bCHF 333.6m-CHF 81,088,264.001.7x-19.6x4.8x
Wed, 14 Aug 2024CHF 759.9mCHF 170.7m-CHF 141,356,264.001.9x-5.4x4.5x
Fri, 12 Jul 2024CHF 753.1mCHF 151.7m-CHF 146,197,264.001.4x-5.2x5x
Sun, 09 Jun 2024CHF 624.2mCHF 169.5m-CHF 139,093,527.380.8x-4.5x3.7x
Tue, 07 May 2024CHF 484.3mCHF 170.9m-CHF 134,982,252.120.9x-3.6x2.8x
Thu, 04 Apr 2024CHF 372.5mCHF 67.4m-CHF 173,184,915.840.2x-2.2x5.5x
Sat, 02 Mar 2024CHF 360.1mCHF 55.6m-CHF 173,212,672.720.2x-2.1x6.5x
Mon, 29 Jan 2024CHF 356.5mCHF 317.6m-CHF 175,988,325.000.8x-2x1.1x
Wed, 27 Dec 2023CHF 297.6mCHF 317.5m-CHF 176,051,067.000.7x-1.7x0.9x
Fri, 24 Nov 2023CHF 294.4mCHF 318.1m-CHF 210,721,608.00n/a-1.4x0.9x
Sun, 22 Oct 2023CHF 255.6mCHF 318.1m-CHF 212,860,970.00n/a-1.2x0.8x
Tue, 19 Sep 2023CHF 280.9mCHF 318.0m-CHF 219,087,995.00n/a-1.3x0.9x
Thu, 17 Aug 2023CHF 515.1mCHF 325.9m-CHF 175,696,296.00n/a-2.9x1.6x
Sat, 15 Jul 2023CHF 315.7mCHF 319.3m-CHF 179,676,031.00n/a-1.8x1x
Mon, 12 Jun 2023CHF 326.3mCHF 333.4m-CHF 181,065,590.00n/a-1.8x1x
Wed, 10 May 2023CHF 362.2mCHF 497.6m-CHF 18,439,790.001.6x-19.6x0.7x
Fri, 07 Apr 2023CHF 407.2mCHF 485.5mCHF 12.4m1.5x32.8x0.8x
Sun, 05 Mar 2023CHF 487.8mCHF 493.4mCHF 14.5m1.7x33.6x1x
Tue, 31 Jan 2023CHF 504.3mCHF 493.4mCHF 14.5m1.6x34.8x1x
Thu, 29 Dec 2022CHF 490.7mCHF 493.4mCHF 14.5m1.6x33.8x1x
Sat, 26 Nov 2022CHF 515.0mCHF 493.4mCHF 14.5m1.7x35.5x1x
Mon, 24 Oct 2022CHF 523.7mCHF 511.7mCHF 15.9m2x33x1x
Wed, 21 Sep 2022CHF 524.1mCHF 500.4mCHF 16.0m1.9x32.8x1x
Fri, 19 Aug 2022CHF 513.2mCHF 485.6mCHF 38.7m1.8x13.3x1.1x
Sun, 17 Jul 2022CHF 528.7mCHF 491.7mCHF 42.2m1.8x12.5x1.1x
Tue, 14 Jun 2022CHF 540.9mCHF 465.2mCHF 82.3m1.9x6.6x1.2x
Thu, 12 May 2022CHF 685.3mCHF 303.6m-CHF 143,963,273.001.9x-4.8x2.3x
Sat, 09 Apr 2022CHF 1.1bCHF 289.3m-CHF 142,900,952.002x-8x4x
Mon, 07 Mar 2022CHF 1.3bCHF 281.0m-CHF 139,133,369.002x-9x4.5x
Wed, 02 Feb 2022CHF 5.3bCHF 318.4m-CHF 658,888,259.001.8x-8x16.7x
Fri, 31 Dec 2021CHF 4.4bCHF 316.1m-CHF 659,207,835.002x-6.6x13.8x
Sun, 28 Nov 2021CHF 3.7bCHF 318.4m-CHF 658,878,564.001.5x-5.6x11.6x
Price to Earnings Ratio

-5.6x


Total Market Cap: CHF 3.7bTotal Earnings: -CHF 658,878,564.00Total Revenue: CHF 318.4mTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Biotech Industry Price to Earnings3Y Average 4.7x202220232024
Current Industry PE
  • Investors are optimistic on the Swiss Biotechs industry, and appear confident in long term growth rates.
  • The 3-year average PS ratio of 3.3x is lower than the industry's current PS ratio of 5.1x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have improved over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that companies overall are more efficiently conducting business since losses are shrinking while sales have been flat.

Industry Trends

Which industries have driven the changes within the Swiss Healthcare industry?

CH Market-1.36%
Healthcare-3.40%
Biotech-11.10%
Biotech-11.10%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
SPEX SpexisCHF 0.05150.0%
+CHF 2.0m		11.1%PS5.7x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

IDIA

CHF 0.72

Idorsia

7D

-21.0%

1Y

-58.8%

RLF

CHF 5.34

Relief Therapeutics Holding

7D

-17.6%

1Y

182.5%

MOLN

CHF 4.80

Molecular Partners

7D

-7.7%

1Y

23.1%

KURN

CHF 24.35

Kuros Biosciences

7D

-16.6%

1Y

532.5%

Kuros Biosciences AG's (VTX:KURN) Shares Climb 30% But Its Business Is Yet to Catch Up

Oct 24
Kuros Biosciences AG's (VTX:KURN) Shares Climb 30% But Its Business Is Yet to Catch Up

ADXN

CHF 0.06

Addex Therapeutics

7D

-3.5%

1Y

35.3%

SANN

CHF 8.32

Santhera Pharmaceuticals Holding

7D

-1.2%

1Y

-11.3%

BSLN

CHF 40.35

Basilea Pharmaceutica

7D

-1.6%

1Y

12.9%

SPEX

CHF 0.05

Spexis

7D

150.0%

1Y

11.1%